S100B and myeloid sarcoma: Various molecules, including glial fibrillary acidic protein (GFAP), neurofilaments (NFs), ubiquitin C-terminal hydrolase (UCHL1) and glial protein with the calcium-binding domain (S100B), are suspected to be potential biomarkers of neurodegeneration in MS [20].